Egypt in Talks with Argentina, India and US on Wheat Imports

A farmer tends wheat at a field in El-Kalubia governorate, northeast of Cairo, March 1, 2022. REUTERS/Mohamed Abd El Ghany
A farmer tends wheat at a field in El-Kalubia governorate, northeast of Cairo, March 1, 2022. REUTERS/Mohamed Abd El Ghany
TT

Egypt in Talks with Argentina, India and US on Wheat Imports

A farmer tends wheat at a field in El-Kalubia governorate, northeast of Cairo, March 1, 2022. REUTERS/Mohamed Abd El Ghany
A farmer tends wheat at a field in El-Kalubia governorate, northeast of Cairo, March 1, 2022. REUTERS/Mohamed Abd El Ghany

Egypt is in talks with Argentina, India, France and the United States for future wheat imports but is in no rush to buy at the moment, the supply minister said on Thursday.

Egypt, one of the world's biggest wheat importers, is looking for alternatives to Black Sea grain exports which face disruptions caused by Russia's invasion of Ukraine, both major wheat exporters to Egypt. Global grain prices have soared.

"There's no need for tenders right now but we are planning for the entire year so we are open to all possibilities and preparing backup plans," Supply Minister Ali Moselhy said.

He said Egypt could start tendering again in the local mid-harvest period, which typically starts in April and ends in July or August. The government aims to procure 6 million tons of wheat from the local harvest.

The minister said the government had already held talks with the United States and France and would meet Argentinian representatives next week.

Indian suppliers still have to seek accreditation as an import origin from state buyer the General Authority for Supply Commodities (GASC), Reuters reported.

The government set a fixed price for unsubsidized bread this week after bread prices jumped 25% to 1.25 Egyptian pounds($0.07) per loaf in some bakeries. Flour prices had also reached highs of 11,000 Egyptian pounds ($602.70) per ton in the weeks since the invasion.

The supply ministry said it would begin offering flour to the private sector at 8,600 Egyptian pounds ($471.23) per ton, and would penalize for violators of the fixed prices from Saturday, the minister added.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.